Skip to content

Post-Market Clinical Follow-up Study of A-SPINE's Products

Post-Market Clinical Follow-up Study of A-SPINE's Products

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04848376
Enrollment
200
Registered
2021-04-19
Start date
2019-09-09
Completion date
2022-09-08
Last updated
2021-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deformity, Degenerative Disc Disease, Kyphosis, Pseudoarthrosis of Spine, Scoliosis, Stenosis, Trauma, Tumor

Brief summary

This is a post-market clinical follow-up study that use questionnaires such as Visual Analog Scale (VAS), the Neck Disability Index (NDI), or the Oswestry Disability Index (ODI) to compare the clinical improvement effects before and after surgery.

Detailed description

The purpose of study is to confirm the safety and and performance of the A-SPINE's products for using 2 years. This post-market clinical follow-up study use questionnaires such as Visual Analog Scale (VAS), the Neck Disability Index (NDI), or the Oswestry Disability Index (ODI) to evaluate the clinical improvement effects. Subjects will be evaluated at pre-operation, 6 months, 12 months, and 2 years post treatment. Finally, analyze the clinical outcome, fusion rate, and adverse events.

Interventions

DEVICE(1) SmartLoc (2) SmartLoc Evo (3) Winloc(4) Vigor PEEK Cervical Disc Spacer (5) Combo C (6) Polymer Lumbar Disc Spacer (7) X'Plo (8) Rainboo (9) Combo L

As long as there are patients using the above device, conduct questionnaire interview.

Sponsors

A-Spine Asia Co., Ltd.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Subject is above 20 years of age; * Subject is indicated for A-SPINE Spinal Fixation System; * Subject is willing and able to provide informed consent to participate in the study; * Subject is willing and able to understand the purpose of the study, his/her role, and is available to return to the clinic/hospital for all required follow-up visits.

Exclusion criteria

* Subjects will be excluded if, in the opinion of the Investigator, the subject does not qualify based on approved labeling requirements or Subject Inclusion Criteria.

Design outcomes

Primary

MeasureTime frameDescription
Visual Analogue Scale- Change from baseline at 2 yearChange from baseline at 2 yearVisual Analogue Scale is a patient-reported outcome measure. The scale ranges from 0 to 10. A score of 0 represents no pain, while a score of 10 represents extreme pain. Compare baseline and postoperative improvement VAS scores.

Secondary

MeasureTime frameDescription
Neck Disability IndexBaseline, 6 months, 12 months, 24 monthsThe NDI is a questionnaire that is commonly used in clinical trials to measure the self-reported functional status of patients with neck pain.The ten questions are measured on a 6-point scale from 0 (no disability) to 5 (full disability). Compare baseline and postoperative improvement NDI scores.
Oswestry Disability IndexBaseline, 6 months,12 months, 24 monthsThe ODI is a questionnaire that is commonly used in clinical trials to measure the self-reported functional status of patients with neck pain.The ten questions are measured on a 6-point scale from 0 (no disability) to 5 (full disability). Compare baseline and postoperative improvement ODI scores.
Number of Device-related Adverse EventsBaseline, 6 months,12 months, 24 monthsAdverse events associated with the device will be assessed at each follow-up visit and the number of cases at the 2-year follow-up will be counted.
Fusion RateBaseline, 6 months,12 months, 24 monthsUse X-ray or CT to detect the spine fusion.

Countries

Taiwan

Contacts

Primary ContactShu-Ting LIU, MS
charlotte@aspine.com.tw+886-2-29267088

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026